Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Telectronics Guardian ATP2 ICD could get panel review this year, company says.

This article was originally published in The Gray Sheet

Executive Summary

TELECTRONICS GUARDIAN ATP2 IMPLANTABLE DEFIBRILLATOR FDA PANEL REVIEW could occur later this year, the company says. Telectronics is hoping that a premarket approval application for its second-generation implantable cardioverter defibrillator will be reviewed by FDA's Circulatory System Devices Advisory Panel at a meeting scheduled for late August. The company submitted the PMA to FDA last summer.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004195

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel